Testing effectiveness (Phase 2)Active Not RecruitingNCT06388564
What this trial is testing
Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
Who this might be right for
Chronic Graft-versus-host-disease
Incyte Corporation 130